Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial

NARecruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

December 1, 2027

Study Completion Date

December 31, 2027

Conditions
Prostate Cancer
Interventions
DEVICE

Barrigel

Barrigel is an absorbable gel based on Non-Animal Stabilized Hyaluronic Acid (NASHA™) that is injected into the peri-rectal space

DEVICE

Transrectal Ultrasound

All subjects will have a transrectal ultrasound (TRUS) conducted. In the control subjects this will act as a sham procedure. For the investigational subjects, the TRUS will be used to visualize the placement of the needle

Trial Locations (5)

3002

RECRUITING

GenesisCare Ringwood, Melbourne

77027

ACTIVE_NOT_RECRUITING

Houston Metro Urology, Houston

78745

RECRUITING

Urology Austin, Austin

02215

RECRUITING

Dana Farber Cancer Institute, Boston

07013

RECRUITING

Summit Health, Clifton

Sponsors
All Listed Sponsors
collaborator

Teleflex

INDUSTRY

lead

Palette Life Sciences, Inc.

INDUSTRY